| dc.contributor.author | Shruthi, N.R. | |
| dc.contributor.author | Das, B.V. | |
| dc.contributor.author | Kamat, V. | |
| dc.contributor.author | Akki, M. | |
| dc.contributor.author | Barretto, D.A. | |
| dc.contributor.author | Poojary, B. | |
| dc.contributor.author | Venugopala, K.N. | |
| dc.date.accessioned | 2026-04-30T06:05:53Z | |
| dc.date.available | 2026-04-30T06:05:53Z | |
| dc.date.issued | 2026 | |
| dc.identifier.citation | Journal of Molecular Structure. 1367; 2026; ArticleID_146171. | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.molstruc.2026.146171 | |
| dc.identifier.uri | http://irgu.unigoa.ac.in/drs/handle/unigoa/7859 | |
| dc.description.abstract | In type II diabetes mellitus, inhibition of the enzymes Alpha-amylase and Alpha-glucosidase is an effective strategy for managing postprandial hyperglycemia. Given the therapeutic significance of Alpha-amylase and Alpha-glucosidase inhibition, this study reports the synthesis of twelve S-alkylated pyridyl-linked oxadiazole thione derivatives from 2-chloronicotinic acid via a multistep synthetic route, evaluated as potential antidiabetic agents, which have been well characterized by FT-IR, sup(1)H/ sup(13)C NMR, and mass spectroscopic techniques. The synthesized compounds were docked with target proteins Alpha-glucosidase (PDB: 3L4Y) and Alpha-amylase (PDB: 4GQR). All synthesized compounds were assessed in vitro for their inhibitory activity against Alpha-amylase and Alpha-glucosidase, along with their anti-inflammatory potential. Compound 6f showed excellent Alpha-amylase and Alpha-glucosidase, and 6g showed anti-inflammatory properties among all the screened compounds. | en_US |
| dc.publisher | Elsevier | en_US |
| dc.subject | Biochemistry | en_US |
| dc.title | S-alkylated pyridyl-linked oxadiazole thione derivatives: Synthesis, dual Alpha-amylase/Alpha-glucosidase inhibition, and anti-inflammatory evaluation | en_US |
| dc.type | Journal article | en_US |
| dc.identifier.impf | y |